Femme et Homme
- | Pays :
- France
- United States
- | Organes : -
- | Spécialités : -
Extrait
The purpose of the study is to compare the efficacy and safety of masitinib 6 mg/kg/day in combination with bortezomib and dexamethasone to placebo in combination with bortezomib and dexamethasone in the treatment of patients with relapsing multiple myeloma who have received one previous therapy.
Critère d'inclusion
- Multiple myeloma